Neuralink has dominated the brain-chip story for two years. It now has a serious challenger with a patient of its own. Paradromics, an Austin neurotech firm, has implanted its Connexus brain-computer interface in the first participant of its FDA-approved clinical study, the company said. The patient
โก
Key Insights
10 editorial insights.
AiFeed24 Teamยทโฑ 1 min readยทNews
Deep Analysis
Multi-Source Intelligence
Tags:#technology
Found this useful? Share it!
Related Stories
๐ฐ
Comparing ReMarkable Paper Pure and Kindle Scribe: My Budget Choice
The US is paying an AI startup $500M to break Chinaโs grip on chip materials
๐ฐ
Google's big Android sideloading crackdown has a 24-hour catch - how the new limits work

